1390P Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes

I Bahce, SMS Hashemi, MF Fransen, JD Veltman, FBJM Thunnissen

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
Publication statusPublished - 2020
EventEuorpean Society for medical oncology: ESMO annual meeting 2020 -
Duration: 14 Sept 2020 → …


ConferenceEuorpean Society for medical oncology
Abbreviated titleESMO
Period14/09/2020 → …

Cite this